Clinical trial
Reversal of a Defunctioning Ileostomy 3 Weeks After the Index Operation, RCT
NCT05192018 is registered in ClinicalTrials.gov with National Cancer Institute, Egypt as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Reversal of a Defunctioning Ileostomy 3 Weeks After the Index Operation, RCT
- Lead sponsor
- National Cancer Institute, Egypt
- Phase
- Not applicable
- Overall status
- Unknown status
- Start date
- December 25, 2021
- Completion date
- July 25, 2023
- Enrollment
- 60 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
colo-rectal cancer